James P Patton Net Worth & Insider Trades
James P Patton - Director, Advaxis, Inc
What is James P Patton's Net Worth?
The current estimated net worth of Advaxis, Inc's Director, James P Patton, is estimated to be about $395.24K . James P Patton owns about 87,909 units of Advaxis, Inc common stock. In the last 3 years at Advaxis, Inc, James P Patton has sold an estimated value of $0 worth.
What is James P Patton's Past Insider Trading?
James P Patton's largest purchase order was 25,000 units , worth over $100K on October 29, 2013. In total, James P Patton has made about 3 transactions over 3 years of their time at Advaxis, Inc. James P Patton usually trades in October, with the busiest year in 2013.
James Patton
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is James P Patton's' Mailing Address?
- Mailing address is 1937 Swedesford Road Malvern PA 19355 PA
Advaxis, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Kenneth Berlin | 2020 | $554,320 | $554,320 | - | $26,000 | $53,809 | $1,188,449 |
| Kenneth Berlin | 2019 | $551,750 | $240,000 | - | $146,398 | $45,588 | $983,736 |
| Molly Henderson | 2020 | $369,163 | - | - | $26,000 | $18,593 | $413,756 |
| Molly Henderson | 2019 | $397,896 | $120,000 | - | $58,498 | $20,052 | $596,446 |
| Andres Gutierrez | 2020 | $426,130 | $170,560 | - | $26,000 | $27,575 | $650,265 |
| Andres Gutierrez | 2019 | $424,423 | $120,000 | - | $58,498 | $24,346 | $627,267 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1100397/000149315221009377/def14a.htm
What are Advaxis, Inc's Past Insider Trades?
Advaxis, Inc's most recent insider trade came on March 16, 2020 by Roni Appel who sold 3,000 units worth $1.7K . In the last 13 years, insiders at Advaxis, Inc have sold an estimated value of $11.98M and bought an estimated value of $21.93M worth of shares. Insider trading is most common in November, with the busiest year in 2015. The most active traders at the company are Robert Petit, Chief Scientific Officer, Sara Bonstein, Chief Financial Officer, and Daniel O'Connor, Chief Executive Officer .
Ayala Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||